Inherited antithrombin deficiency and anabolic steroids: a risky combination.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Blood Coagulation and Fibrinolysis

• Publication date

  2016-09-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/MBC.0000000000000454PMID 26588446
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Successful treatment with rivaroxaban of an extended superficial vein thrombosis in a patient with acquired antithrombin deficiency due to Peg-asparaginase treatment

  2015cited by this paper
• Testosterone, thrombophilia, thrombosis.

  2015cited by this paper
• Testosterone, thrombophilia, thrombosis

  2014cited by this paper
• Thrombotic events after starting exogenous testosterone in men with previously undiagnosed familial thrombophilia.

  2011cited by this paper
• Pulmonary Embolism Associated With Protein C Deficiency and Abuse of Anabolic-androgen Steroids

  2010cited by this paper
• The effects of injected testosterone dose and age on the conversion of testosterone to estradiol and dihydrotestosterone in young and older men.

  2010cited by this paper
• Adverse events associated with testosterone administration.

  2010cited by this paper
• Role of antithrombin concentrate in treatment of hereditary antithrombin deficiency

  2009cited by this paper
• Pulmonary embolism associated with the use of anabolic steroids.

  2008cited by this paper
• Inherited antithrombin deficiency: a review

  2008cited by this paper
• Risk of a first venous thrombotic event in carriers of a familial thrombophilic defect. The European Prospective Cohort on Thrombophilia (EPCOT)

  2005cited by this paper
• Androgen-induced cerebral venous sinus thrombosis in a young body builder: case report

  2004cited by this paper
• Different risks of thrombosis in four coagulation defects associated with inherited thrombophilia: a study of 150 families.

  1998cited by this paper
• Testosterone increases human platelet thromboxane A2 receptor density and aggregation responses.

  1995cited by this paper
• Evolution of serum erythropoietin after androgen administration to hemodialysis patients: a prospective study.

  1995cited by this paper
• Inherited Antithrombin Deficiency Causing Thrombophilia

  1965cited by this paper

• Higher dose of rivaroxaban for the treatment of venous thromboembolism in a 15-year-old Asian child with antithrombin deficiency: A case report and literature review

  2025cites this paper
• Effects of Exogenous Androgens on Platelet Activity and Their Thrombogenic Potential in Supraphysiological Administration: A Literature Review

  2021cites this paper
• Severe Cardiac and Metabolic Pathology Induced by Steroid Abuse in a Young Individual

  2021cites this paper
• Anabolic Androgenic Steroid Abuse: The Effects on Thrombosis Risk, Coagulation, and Fibrinolysis

  2018cites this paper
• The Successful Prevention of Thromboembolism Using Rivaroxaban in a Patient with Antithrombin Deficiency during the Perioperative Period

  2017cites this paper
• Thromboembolism peaking 3 months after starting testosterone therapy: testosterone–thrombophilia interactions

  2017cites this paper